These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 15916224)
21. Efficacy of tetracyclines in the treatment of acne vulgaris: a review. Simonart T; Dramaix M; De Maertelaer V Br J Dermatol; 2008 Feb; 158(2):208-16. PubMed ID: 17986300 [TBL] [Abstract][Full Text] [Related]
22. Tetracyclines: new look at old antibiotic. II. Clinical use. Siegel D N Y State J Med; 1978 Jun; 78(7):1115-20. PubMed ID: 149261 [No Abstract] [Full Text] [Related]
23. Oral Tetracyclines and Acne: A Systematic Review for Dermatologists. Armstrong AW; Hekmatjah J; Kircik LH J Drugs Dermatol; 2020 Nov; 19(11):s6-s13. PubMed ID: 33196746 [TBL] [Abstract][Full Text] [Related]
24. A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris. Del Rosso JQ; Schmidt NF Cutis; 2010 Jan; 85(1):15-24. PubMed ID: 20184207 [TBL] [Abstract][Full Text] [Related]
27. Tetracyclines: what a rheumatologist needs to know? Attar SM Int J Rheum Dis; 2009 Jul; 12(2):84-9. PubMed ID: 20374324 [TBL] [Abstract][Full Text] [Related]
28. [Acne vulgaris--principles and results of treatment with retinoic acid and tetracyclines (author's transl)]. Wolff-Schreiner E; Stingl G; Mach K Wien Klin Wochenschr; 1977 Mar; 89(6):177-84. PubMed ID: 139762 [TBL] [Abstract][Full Text] [Related]
30. Sarecycline Review. Haidari W; Bruinsma R; Cardenas-de la Garza JA; Feldman SR Ann Pharmacother; 2020 Feb; 54(2):164-170. PubMed ID: 31462063 [No Abstract] [Full Text] [Related]
31. Use of macrolides and tetracyclines for chronic inflammatory diseases. Voils SA; Evans ME; Lane MT; Schosser RH; Rapp RP Ann Pharmacother; 2005 Jan; 39(1):86-94. PubMed ID: 15562139 [TBL] [Abstract][Full Text] [Related]
32. Omadacycline: First Global Approval. Markham A; Keam SJ Drugs; 2018 Dec; 78(18):1931-1937. PubMed ID: 30471003 [TBL] [Abstract][Full Text] [Related]
33. Do tetracyclines and erythromycin exert anti-acne effects by inhibition of P450-mediated degradation of retinoic acid? Hellmann-Regen J; Herzog I; Fischer N; Heuser I; Regen F Exp Dermatol; 2014 Apr; 23(4):290-3. PubMed ID: 24690039 [TBL] [Abstract][Full Text] [Related]
35. The treatment of acne. Part III: antibacterials. Kligman AM Cutis; 1995 Dec; 56(6):315-6. PubMed ID: 8654122 [No Abstract] [Full Text] [Related]
36. Systemic treatment of acne. Hansen SR; Mikkelsen CS; Kroon S Tidsskr Nor Laegeforen; 2011 Jan; 131(2):133-5. PubMed ID: 21267031 [No Abstract] [Full Text] [Related]
37. Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics. Part 1: tetracyclines. Barza M; Schiefe RT Am J Hosp Pharm; 1977 Jan; 34(1):49-57. PubMed ID: 318799 [TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris. Marta Guarna M; Coulson R; Rubinchik E FEMS Microbiol Lett; 2006 Apr; 257(1):1-6. PubMed ID: 16553825 [TBL] [Abstract][Full Text] [Related]
39. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report. Leyden JJ; Del Rosso JQ; Webster GF Dermatol Clin; 2009 Jan; 27(1):1-15. PubMed ID: 18984363 [TBL] [Abstract][Full Text] [Related]